Antiphospholipid antibodies and thrombosis: Do test patterns identify the patients' risk?

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 597-601

  Galli, Monica ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Antiphospholipid antibodies; Patterns; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLOOD CLOTTING TEST; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; THROMBOSIS; VEIN THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; MALE; ODDS RATIO; PROTHROMBIN; RETROSPECTIVE STUDIES; RISK; THROMBOSIS;

EID: 7044250862     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.08.009     Document Type: Conference Paper

References (19)

1. W.A. Wilson, A.E. Gharavi, and T. Koike International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome Arthritis Rheum. 42 1999 1309 1311
2. M. Galli, P. Comfurius, and C. Maassen Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1990 1544 1547
3. H.P. McNeil, R.J. Simpson, C.N. Chesterman, and S.A. Krilis Antiphospholipid antibodies are directed against a complex antigen that include a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) Proc. Natl. Acad. Sci. U. S. A. 87 1990 4120 4127
4. E. Matsuura, Y. Igarashi, and M. Fujimoto Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Lancet 336 1990 177 178
5. E.M. Bevers, M. Galli, T. Barbui, P. Comfurius, and R.F.A. Zwaal Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb. Haemost. 66 1991 629 632
6. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832
7. 2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome Blood 102 2003 2717 2723
8. J.T. Brandt, D.A. Triplett, B. Alving, and I. Scharrer Criteria for the diagnosis of lupus anticoagulants: an update Thromb. Haemost. 74 1995 1185 1190
9. M. Galli, J. Dlott, and F. Norbis Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests Thromb. Haemost. 84 2000 1012 1016
10. E.N. Harris, A.E. Gharavi, and G.R.V. Hughes The anticardiolipin assay E.N. Harris T. Exner G.R.V. Hughes R.A. Asherson Phospholipid-binding antibodies 1991 CRC Press Boca Raton (FL) 175 187
11. R.C.W. Wong, E.J. Favaloro, and W. Pollock A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays Pathology 36 2004 182 192
12. R.C.W. Wong, D. Gillis, and S. Adelstein Consensus guidelines on anti-cardiolipin antibody testing and reporting Pathology 36 2004 63 68
13. A. Tincani, F. Allegri, and M. Sanmarco Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum Thromb. Haemost. 86 2001 575 583
14. G. Reber, I. Schousboe, and A. Tincani Inter-laboratory variability of anti-beta 2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on antiphospholipid antibodies standardization group Thromb. Haemost. 88 2002 66 73
15. M. Greaves, H. Cohen, S.I. Machin, and I. Mackie Guidelines on the investigation and management of the antiphospholipid syndrome Br. J. Haematol. 109 2000 704 715
16. M. Galli, G. Finazzi, and F. Norbis The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile Thromb. Haemost. 81 1999 695 701
17. I. Jennings, M. Greaves, I.J. Mackie, S. Kitchen, T.A.L. Woods, and F.E. Preston Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods Br. J. Haematol. 119 2002 364 369
18. A. Le Querrec, J. Arnout, and D. Arnoux Quantification of lupus anticoagulants in clinical samples using anti-beta 2-glycoprotein I and anti-prothrombin monoclonal antibodies Thromb. Haemost. 86 2001 584 589
19. J. Arnout, P. Meijer, and J. Vermylen Lupus anticoagulant testing in Europe: an analysis of results from the first European concerted action of thrombophilia (ECAT) survey using plasma spiked with monoclonal antibodies against human beta 2-glycoprotein I Thromb. Haemost. 81 1999 929 934